What are the obligations of pharmaceutical companies in a global health emergency?

10.1016/S0140-6736(21)01378-7

Saved in:

Bibliographic Details
Main Authors:	Emanuel, EJ, Buchanan, A, Chan, SY, Fabre, C, Halliday, D, Heath, J, Herzog, L, Leland, RJ, McCoy, MS, Norheim, OF, Saenz, C, Schaefer, GO, Tan, KC, Wellman, CH, Wolff, J, Persad, G
Other Authors:	DEAN'S OFFICE (MEDICINE)
Format:	Review
Published:	Elsevier BV 2022
Subjects:	Costs and Cost Analysis Developing Countries Drug Industry Global Health Humans Social Responsibility
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/228267
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-228267
record_format	dspace
spelling	sg-nus-scholar.10635-2282672022-07-12T04:28:05Z What are the obligations of pharmaceutical companies in a global health emergency? Emanuel, EJ Buchanan, A Chan, SY Fabre, C Halliday, D Heath, J Herzog, L Leland, RJ McCoy, MS Norheim, OF Saenz, C Schaefer, GO Tan, KC Wellman, CH Wolff, J Persad, G DEAN'S OFFICE (MEDICINE) Costs and Cost Analysis Developing Countries Drug Industry Global Health Humans Social Responsibility 10.1016/S0140-6736(21)01378-7 The Lancet 398 10304 1015-1020 2022-07-12T04:07:37Z 2022-07-12T04:07:37Z 2021-09-11 2022-07-06T06:09:33Z Review Emanuel, EJ, Buchanan, A, Chan, SY, Fabre, C, Halliday, D, Heath, J, Herzog, L, Leland, RJ, McCoy, MS, Norheim, OF, Saenz, C, Schaefer, GO, Tan, KC, Wellman, CH, Wolff, J, Persad, G (2021-09-11). What are the obligations of pharmaceutical companies in a global health emergency?. The Lancet 398 (10304) : 1015-1020. ScholarBank@NUS Repository. https://doi.org/10.1016/S0140-6736(21)01378-7 01406736 1474547X https://scholarbank.nus.edu.sg/handle/10635/228267 Elsevier BV Elements
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	Costs and Cost Analysis Developing Countries Drug Industry Global Health Humans Social Responsibility
spellingShingle	Costs and Cost Analysis Developing Countries Drug Industry Global Health Humans Social Responsibility Emanuel, EJ Buchanan, A Chan, SY Fabre, C Halliday, D Heath, J Herzog, L Leland, RJ McCoy, MS Norheim, OF Saenz, C Schaefer, GO Tan, KC Wellman, CH Wolff, J Persad, G What are the obligations of pharmaceutical companies in a global health emergency?
description	10.1016/S0140-6736(21)01378-7
author2	DEAN'S OFFICE (MEDICINE)
author_facet	DEAN'S OFFICE (MEDICINE) Emanuel, EJ Buchanan, A Chan, SY Fabre, C Halliday, D Heath, J Herzog, L Leland, RJ McCoy, MS Norheim, OF Saenz, C Schaefer, GO Tan, KC Wellman, CH Wolff, J Persad, G
format	Review
author	Emanuel, EJ Buchanan, A Chan, SY Fabre, C Halliday, D Heath, J Herzog, L Leland, RJ McCoy, MS Norheim, OF Saenz, C Schaefer, GO Tan, KC Wellman, CH Wolff, J Persad, G
author_sort	Emanuel, EJ
title	What are the obligations of pharmaceutical companies in a global health emergency?
title_short	What are the obligations of pharmaceutical companies in a global health emergency?
title_full	What are the obligations of pharmaceutical companies in a global health emergency?
title_fullStr	What are the obligations of pharmaceutical companies in a global health emergency?
title_full_unstemmed	What are the obligations of pharmaceutical companies in a global health emergency?
title_sort	what are the obligations of pharmaceutical companies in a global health emergency?
publisher	Elsevier BV
publishDate	2022
url	https://scholarbank.nus.edu.sg/handle/10635/228267
_version_	1738844679859863552

What are the obligations of pharmaceutical companies in a global health emergency?

Similar Items